Executives On The Move: Exits Are In the News This Week From Bristol-Myers Squibb, Glenmark And EMD Serono
Executive Summary
Daiichi Sankyo appoints former Bristol-Myers Squibb global head of talent as its chief people officer and Glenmark CMO switches to same position at cellular medicines firm Mesoblast Ltd. At GlaxoSmithKline, an EMD Serono SVP will be president, US Pharma.